BGP Pharma ULC — licence 102234, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00443832 | DEPAKENE | BGP PHARMA ULC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02532441 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP PHARMA CORPORATION | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02549190 | ODAN-VALPROIC ACID | ODAN LABORATORIESLTD | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02236807 | PMS-VALPROIC ACID | PHARMASCIENCE INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Marketed |
| 02238069 | VALPROIC ACID ORAL SOLUTION | APOTEX INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Approved |
| 02238370 | APO-VALPROIC ACID ORAL SOLUTION | APOTEX INC | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Dormant |
| 02238042 | DEPROIC SYRUP | TECHNILAB PHARMA INC. | Syrup | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238817 | DOM-VALPROIC ACID | DOMINION PHARMACAL | Solution | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02238368 | EPIJECT I.V. | ABBOTT LABORATORIES, LIMITED | Liquid | VALPROIC ACID (SODIUM VALPROATE) 500 MG | Cancelled Post Market |
| 02238210 | PHL-VALPROIC ACID | PHARMEL INC | Syrup | VALPROIC ACID (SODIUM VALPROATE) 250 MG | Cancelled Post Market |
| 02140063 | RATIO-VALPROIC 50MG/ML SYRUP | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Syrup | VALPROIC ACID (SODIUM VALPROATE) 50 MG | Cancelled Post Market |